The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

HBIO FINANCIAL STATEMENTS

Harvard Bioscience Inc — balance sheet, income statement and cash flow trends

HBIOHarvard Bioscience Inc

🇺🇸 USA · NASDAQ · Healthcare · Medical Instruments & Supplies

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-50 M050 M100 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue87.8 M $Gross Profit51.1 M $ · 58%Operating Income1 M $ · 1%Pre-tax Income-10.5 M $ · -12%Net Income to Owners-10.4 M $ · -12%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue87.8 M $-1.1%
Gross Profit51.1 M $+3.5%
Operating Income1 M $—
EBITDA-939 K $—
Net Income to Owners-10.4 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
050 M100 M150 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets76.3 M
  • Equity7.4 M $10%
  • Current Liabilities24.8 M $33%
  • Long-term Liabilities44.1 M $58%

Key Figures

YoY change
Total Assets76.3 M $-4.8%
Total Liabilities68.9 M $+7.0%
Total Equity7.4 M $-52.9%
Cash & ST Investments6.5 M $-12.6%
Total Debt36.7 M $-15.3%
Net Debt30.2 M $-15.9%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
010 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-1 M0651 K $Operating-2.5 M $Investing1.1 M $Financing-708 K $Net Change

Key Figures

YoY change
Operating Cash Flow651 K $-90.2%
Capital Expenditures2.1 M $-17.3%
Free Cash Flow-1.4 M $-134.1%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on HBIO

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.